Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Lymphocytic, Chronic, B-Cell × dexamethasone 21-phosphate × 90 days × Clear all

Sponsor

Conditions

Multiple Myeloma 14 Burkitt Lymphoma 7 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Neoplasm Metastasis 3 Leukemia, Biphenotypic, Acute 3 Recurrence 2 Smoldering Multiple Myeloma 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Plasmacytoma 1 Neoplasms 1 Myelodysplastic Syndromes 1 Meningioma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Leukemia, Myelomonocytic, Chronic 1 Immunoglobulin Light-chain Amyloidosis 1 Hodgkin Disease 1 Fatigue 1 Down Syndrome 1 Brain Neoplasms 1 Blastic Plasmacytoid Dendritic Cell Neoplasm 1 Ann Arbor Stage II Mantle Cell Lymphoma 1

Interventions

venetoclax 42 Rituximab 25 obinutuzumab 22 ibrutinib 22 Cyclophosphamide 22 acalabrutinib 19 pirtobrutinib 17 fludarabine 17 Specimen Handling 11 zanubrutinib 10 fludarabine phosphate 10 Biopsy 10 Bendamustine Hydrochloride 10 Magnetic Resonance Spectroscopy 7 Whole-Body Irradiation 5 Prednisone 5 Lenalidomide 5 idelalisib 4 Vincristine 4 Mycophenolic Acid 4 Doxorubicin 4 CT-P10 4 ARQ531 4 pembrolizumab 3 Tacrolimus 3 tocilizumab 2 duvelisib 2 daratumumab 2 atezolizumab 2 Therapeutics 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡